首页 > 最新文献

Archives of internal medicine最新文献

英文 中文
Stability of active ingredients in long-expired prescription medications. 长期过期处方药中有效成分的稳定性。
Pub Date : 2012-11-26 DOI: 10.1001/archinternmed.2012.4501
Lee Cantrell, Jeffrey R Suchard, Alan Wu, Roy R Gerona
{"title":"Stability of active ingredients in long-expired prescription medications.","authors":"Lee Cantrell, Jeffrey R Suchard, Alan Wu, Roy R Gerona","doi":"10.1001/archinternmed.2012.4501","DOIUrl":"https://doi.org/10.1001/archinternmed.2012.4501","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1685-7"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archinternmed.2012.4501","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30960669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
Freedom to innovate: the perils of centralized medical research. 创新的自由:集中医学研究的危险。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.53
Marco Huesch, Darius Lakdawalla
{"title":"Freedom to innovate: the perils of centralized medical research.","authors":"Marco Huesch, Darius Lakdawalla","doi":"10.1001/2013.jamainternmed.53","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.53","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1692-3; author reply 1693"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.53","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31075814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress. 临床实践指南未能达到医学研究所的标准:二十年来几乎没有进展,如果有的话。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.56
Justin Kung, Ram R Miller, Philip A Mackowiak
BACKGROUNDIn March 2011, the Institute of Medicine (IOM) issued a new set of standards for clinical practice guidelines intended to enhance the quality of guidelines being produced. To our knowledge, no systematic review of adherence to such standards has been undertaken since one published over a decade ago.METHODSTwo reviewers independently screened 130 guidelines selected at random from the National Guideline Clearinghouse (NGC) website for compliance with 18 of 25 IOM standards.RESULTSThe overall median number (percentage) of IOM standards satisfied (out of 18) was 8 (44.4%), with an interquartile range of 6.5 (36.1%) to 9.5 (52.8%). Fewer than half of the guidelines surveyed met more than 50% of the IOM standards. Barely a third of the guidelines produced by subspecialty societies satisfied more than 50% of the IOM standards surveyed. Information on conflicts of interest (COIs) was given in fewer than half of the guidelines surveyed. Of those guidelines including such information, COIs were present in over two-thirds of committee chairpersons (71.4%) and 90.5% of co-chairpersons. Except for US government agency–produced guidelines, criteria used to select committee members and the selection process were rarely described. Committees developing guidelines rarely included an information scientist or a patient or patient representative. Non-English literature, unpublished data, and/or abstracts were rarely considered in developing guidelines; differences of opinion among committee members generally were not aired in guidelines; and benefits of recommendations were enumerated more often than potential harms. Guidelines published from 2006 through 2011 varied little with regard to average number of IOM standards satisfied.CONCLUSIONAnalysis of a random sample of clinical practice guidelines archived on the NGC website as of June 2011 demonstrated poor compliance with IOM standards, with little if any improvement over the past 2 decades.
背景:2011年3月,医学研究所(IOM)发布了一套新的临床实践指南标准,旨在提高正在制定的指南的质量。据我们所知,自十多年前发布了一项标准以来,还没有对这些标准的遵守情况进行过系统的审查。方法:两名审稿人独立筛选了从国家指南信息中心(NGC)网站随机选择的130份指南,以符合25项IOM标准中的18项。结果:总体满意IOM标准的中位数(百分比)为8(44.4%),四分位数区间为6.5(36.1%)~ 9.5(52.8%)。在接受调查的指南中,只有不到一半的指南达到了国际医学组织标准的50%以上。亚专业协会制定的指南中,只有不到三分之一满足了超过50%的IOM调查标准。在接受调查的准则中,只有不到一半提供了有关利益冲突的信息。在这些包含此类信息的指导方针中,超过三分之二的委员会主席(71.4%)和90.5%的联合主席中都有coi。除了美国政府机构制定的指导方针外,很少对遴选委员会成员的标准和遴选过程进行描述。制定指南的委员会很少包括信息科学家或患者或患者代表。在制定指南时很少考虑非英语文献、未发表的数据和/或摘要;委员会成员之间的意见分歧一般不会在指导方针中公布;推荐的好处比潜在的危害更常被列举出来。2006年至2011年发布的指南在满足国际移民组织标准的平均数量方面变化不大。结论:对2011年6月存档的临床实践指南随机样本的分析表明,对IOM标准的遵守程度很差,在过去的20年里几乎没有任何改善。
{"title":"Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress.","authors":"Justin Kung, Ram R Miller, Philip A Mackowiak","doi":"10.1001/2013.jamainternmed.56","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.56","url":null,"abstract":"BACKGROUND\u0000In March 2011, the Institute of Medicine (IOM) issued a new set of standards for clinical practice guidelines intended to enhance the quality of guidelines being produced. To our knowledge, no systematic review of adherence to such standards has been undertaken since one published over a decade ago.\u0000\u0000\u0000METHODS\u0000Two reviewers independently screened 130 guidelines selected at random from the National Guideline Clearinghouse (NGC) website for compliance with 18 of 25 IOM standards.\u0000\u0000\u0000RESULTS\u0000The overall median number (percentage) of IOM standards satisfied (out of 18) was 8 (44.4%), with an interquartile range of 6.5 (36.1%) to 9.5 (52.8%). Fewer than half of the guidelines surveyed met more than 50% of the IOM standards. Barely a third of the guidelines produced by subspecialty societies satisfied more than 50% of the IOM standards surveyed. Information on conflicts of interest (COIs) was given in fewer than half of the guidelines surveyed. Of those guidelines including such information, COIs were present in over two-thirds of committee chairpersons (71.4%) and 90.5% of co-chairpersons. Except for US government agency–produced guidelines, criteria used to select committee members and the selection process were rarely described. Committees developing guidelines rarely included an information scientist or a patient or patient representative. Non-English literature, unpublished data, and/or abstracts were rarely considered in developing guidelines; differences of opinion among committee members generally were not aired in guidelines; and benefits of recommendations were enumerated more often than potential harms. Guidelines published from 2006 through 2011 varied little with regard to average number of IOM standards satisfied.\u0000\u0000\u0000CONCLUSION\u0000Analysis of a random sample of clinical practice guidelines archived on the NGC website as of June 2011 demonstrated poor compliance with IOM standards, with little if any improvement over the past 2 decades.","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1628-33"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.56","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30996268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 278
Will newer anticoagulants improve therapy persistence? 新的抗凝剂会改善治疗的持久性吗?
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.616
Whitney Maxwell, Charles L Bennett
{"title":"Will newer anticoagulants improve therapy persistence?","authors":"Whitney Maxwell, Charles L Bennett","doi":"10.1001/2013.jamainternmed.616","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.616","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1689-90"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.616","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30997059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Extending the health benefits of clean indoor air policies. 扩大清洁室内空气政策的健康效益。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.269
Sara Kalkhoran, Pamela M Ling
{"title":"Extending the health benefits of clean indoor air policies.","authors":"Sara Kalkhoran, Pamela M Ling","doi":"10.1001/2013.jamainternmed.269","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.269","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1642-3"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.269","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31010603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Freedom to innovate: the perils of centralized medical research-reply. 创新的自由:集中医学研究的危险。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.206
Vinay Prasad, Jason Rho, Adam Cifu
{"title":"Freedom to innovate: the perils of centralized medical research-reply.","authors":"Vinay Prasad, Jason Rho, Adam Cifu","doi":"10.1001/2013.jamainternmed.206","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.206","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1692-3"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.206","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31495504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
About this journal. 关于这本日记。
Pub Date : 2012-11-26 DOI: 10.1001/archinte.172.21.1619
{"title":"About this journal.","authors":"","doi":"10.1001/archinte.172.21.1619","DOIUrl":"https://doi.org/10.1001/archinte.172.21.1619","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1619"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31495506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New drugs and safety: what happened to new active substances approved in Canada between 1995 and 2010? 新药和安全性:1995年至2010年间在加拿大批准的新活性物质发生了什么?
Pub Date : 2012-11-26 DOI: 10.1001/archinternmed.2012.4444
Joel Lexchin
{"title":"New drugs and safety: what happened to new active substances approved in Canada between 1995 and 2010?","authors":"Joel Lexchin","doi":"10.1001/archinternmed.2012.4444","DOIUrl":"https://doi.org/10.1001/archinternmed.2012.4444","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1680-1"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archinternmed.2012.4444","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30961244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 62
There is nothing personal. 这不是针对个人的。
Pub Date : 2012-11-26 DOI: 10.1001/archinternmed.2012.4430
Arnaud Chiolero
{"title":"There is nothing personal.","authors":"Arnaud Chiolero","doi":"10.1001/archinternmed.2012.4430","DOIUrl":"https://doi.org/10.1001/archinternmed.2012.4430","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1691-2; author reply 1692"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archinternmed.2012.4430","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31075813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Lactobacilli vs antibiotics to prevent recurrent urinary tract infections: an inconclusive, not inferior, outcome. 乳酸菌与抗生素预防复发性尿路感染:一个不确定的结果。
Pub Date : 2012-11-26 DOI: 10.1001/archinternmed.2012.4427
Mark Adrian Faasse
{"title":"Lactobacilli vs antibiotics to prevent recurrent urinary tract infections: an inconclusive, not inferior, outcome.","authors":"Mark Adrian Faasse","doi":"10.1001/archinternmed.2012.4427","DOIUrl":"https://doi.org/10.1001/archinternmed.2012.4427","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":"172 21","pages":"1690-1; author reply 1691"},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archinternmed.2012.4427","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31075812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Archives of internal medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1